President-Elect Nominees 2020

INSAR Board Elections 2020 - President-Elect (2 nominees)

 

Joseph D. Buxbaum, PhD & Connie Kasari, PhD

 


 

Joseph D. Buxbaum, PhD

Personal Statement:

As a researcher studying autism for the last 23 years, I remain convinced that the most effective path to improved treatment in ASD, and especially severe ASD, is through the integrated efforts of all stakeholders, including advocates and preclinical and clinical experts. I have agreed to lead a three-year process for rebalancing preclinical and clinical research, as well as psychological, medical and pharmacological sciences, at the INSAR Annual Meeting. As part of this, I have taken steps to ensure that the most advanced and cutting-edge research is presented at Plenary Talks, Panels and Oral Sessions, while also ensuring that all autism research has a place at INSAR. It would be an honor and a pleasure to continue these endeavors as President.

Bio sketch:

Joseph D. Buxbaum, PhD is Professor and Vice-Chair for Research in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai. He is the Director of the Seaver Autism Center for Research and Treatment and, under his direction, the Seaver Autism Center integrated preclinical and clinical research, with direction and input from a broad group of stakeholders, with the ultimate goal of improving treatment, particularly for severe autism. Dr. Buxbaum is a founder and communicating PI of the Autism Sequencing Consortium, currently analyzing whole exome sequencing from 38,000 individuals to identify ASD genes. The Seaver Center focuses on clinical and functional follow up of top autism genes, including developing improved treatments. Dr. Buxbaum is committed to this translational vision in ASD, where preclinical and clinical researchers, working with advocates, identify needs and develop optimal treatment. He believes that INSAR is the optimal environment for such a translational vision, and has been tasked with re-balancing preclinical and clinical research, as well as psychological, medical and pharmacological sciences, at the INSAR Annual Meeting. To accomplish this, he is chairing the Program Committee (2019-2020), and has created an ad hoc Executive Committee (2019-2021), which focuses on identifying gap areas at the Annual Meeting, ensuring that the best research is represented, and emphasizing inclusion. Dr. Buxbaum was elected to the National Academy of Medicine (one of three academies that make up the National Academies of Sciences, Engineering, and Medicine), in 2015.



Connie Kasari, PhD

Personal statement:

INSAR has a simple mission statement: To improve the lives of people affected by autism by promoting the highest quality research. As we begin a new decade, INSAR is poised to make significant inroads on multidisciplinary, translational science that can truly benefit the individuals at the heart of our organization---those with ASD and their families. I would be honored to serve in a leadership position to champion this goal and to continue to increase our global inclusiveness, diversity, and breadth of mentoring and training of the next generation of autism researchers and clinicians.

Bio sketch:

Connie Kasari, Ph.D. is Professor of Human Development & Psychology in the Graduate School of Education and Professor of Psychiatry in the Semel Institute of Neuroscience & Human Behavior at the University of California, Los Angeles. Professor Kasari is a founding member of the Center for Autism Research and Treatment at UCLA. Her research aims to develop novel, evidence-tested interventions for early social communication development in at risk infants, toddlers and preschoolers with ASD, and peer relationships for school aged children with ASD. Her focus has been on interventions implemented in community settings with a lens toward underserved, and under-represented populations. These include minimally verbal children with ASD, children with few resources, and girls with ASD. She leads several large multi-site studies including those on interventions for minimally verbal children with ASD, and a network of researchers that aims to decrease disparities in interventions for children with ASD. She regularly teaches both graduate and undergraduate courses and has been the primary advisor of more than 60 doctoral students.


 

Voting is Open from Friday, February 7, 2020 until Thursday, March 5, 2020.
All voting members, INSAR Full and Student Members, will receive an email with the voting link.

Contact Us

INSAR
International Society for Autism Research
400 Admiral Blvd. | Kansas City, MO 64106
USA

p. 816.595.4852
f.  816.472.7765
e. info@autism-insar.org

Follow Us

© 2018 INSAR | All Rights Reserved